📰 Cell Engager News
Cell Engager News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Engager. Real-time updates on events, politics, business and more.
November 2, 2023
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...
April 13, 2022
Proceeds Support Advancement of the M-gager Platform Technology and Lead Product Candidate CDR404, a First Antibody Fragment-based Dual MAGE-A4 T Cell Engager, and Other Discovery ProgramsZÜRICH, Switzerland
April 13, 2022
Investegate announcements from CDR-Life AG, CDR-Life Announces $76 Million Raised in Series A Funding
February 22, 2022
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.Early clinical outcomes and novel TCE design modifications have fueled the development and clinical advancement of over 65 bispecific T-cell engagers (...
January 11, 2022
On Monday, Lindis Biotech, GmbH filed a complaint in the District of Delaware against Amgen Inc. for allegedly infringing upon their patents for an